Is Aspirin And Dipyridamole still available?

Yes. Aspirin And Dipyridamole (ANDA 210318) is listed with marketing status Prescription in the FDA Orange Book.

What is Aspirin And Dipyridamole a generic of?

Aspirin And Dipyridamole is a generic (ANDA 210318) containing Aspirin; Dipyridamole. Open the active-ingredient family to see the reference-listed brand and other approved products.

What does Aspirin And Dipyridamole's TE code AB mean?

AB is an "A"-rated therapeutic-equivalence code, meaning the FDA considers Aspirin And Dipyridamole substitutable for its reference brand with no expected difference in clinical effect.

What is Aspirin And Dipyridamole's FDA application number?

Aspirin And Dipyridamole is approved under ANDA 210318, held by Glenmark Speclt.

Orange Book product · Generic (ANDA)

Aspirin And Dipyridamole

Aspirin; Dipyridamole

Generic (ANDA)ANDA 210318TE AB Glenmark Speclt

Approved

May 24, 2019

Application

Generic (ANDA)

TE code

Listed patents

Aspirin And Dipyridamole (Aspirin; Dipyridamole) is a generic drug approved under an ANDA (210318) in 2019, marketed by Glenmark Speclt. Its therapeutic-equivalence code is AB, so the FDA considers it substitutable for the reference brand.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

Approval
FDA approval date of this drug product.
May 24, 2019
7 yr 3 mo ago
Today

FDA product record

Pharmaceutical detail

Active ingredient

ASPIRIN; DIPYRIDAMOLE

Strength

25MG;200MG

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

TE code

Application

ANDA 210318

Product number

001

Marketing status

Prescription

Reference listed drug (RLD)

Reference standard (RS)

Yes

Brand + generics

Active-ingredient family

Generic (ANDA) of Aspirin; Dipyridamole

View full Aspirin; Dipyridamole family

Orange Book patent file

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Aspirin And Dipyridamole — frequently asked questions

Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.

Built directly from the FDA Orange Book data file. This product page links back to the Aspirin; Dipyridamole active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.

Related FDA reference tools

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo